|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ACHC | GOLDBERG RANDALL P | VP of Business Development | Mar 14 | Sale | 41.47 | 400 | 16,589 | 5,357 | Mar 16 05:39 PM |
ACHC | GOLDBERG RANDALL P | VP of Business Development | Mar 01 | Sale | 38.47 | 960 | 36,927 | 5,982 | Mar 02 05:02 PM |
ACHC | GOLDBERG RANDALL P | VP of Business Development | May 04 | Option Exercise | 29.39 | 1,000 | 29,390 | 10,607 | May 05 05:01 PM |
ACHC | GOLDBERG RANDALL P | VP of Business Development | May 04 | Sale | 45.18 | 4,925 | 222,512 | 5,682 | May 05 05:01 PM |
ACHC | GOLDBERG RANDALL P | VP of Business Development | Mar 08 | Sale | 43.55 | 914 | 39,802 | 7,376 | Mar 09 06:00 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | Aug 05 | Option Exercise | 23.36 | 1,814 | 42,381 | 12,502 | Aug 09 05:15 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | Aug 05 | Sale | 52.41 | 3,626 | 190,044 | 8,876 | Aug 09 05:15 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | Nov 06 | Sale | 74.01 | 2,824 | 209,005 | 8,090 | Nov 10 05:01 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | May 01 | Option Exercise | 23.37 | 1,812 | 42,350 | 13,474 | Aug 18 06:02 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | May 08 | Option Exercise | 28.82 | 2,262 | 65,187 | 13,044 | Aug 18 06:02 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | Aug 14 | Sale | 80.47 | 723 | 58,180 | 10,914 | Aug 18 06:02 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | May 02 | Sale | 45.25 | 1,016 | 45,974 | 11,174 | Aug 18 06:02 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | Mar 02 | Sale | 65.82 | 392 | 25,801 | 10,782 | Aug 18 06:02 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | May 13 | Sale | 67.50 | 1,856 | 125,280 | 11,662 | May 22 05:01 PM |
ACHC | GOLDBERG RANDALL P | 10% Owner | Nov 03 | Sale | 60.21 | 1,042 | 62,735 | 14,287 | Nov 04 08:31 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite